The purpose of this study is to determine whether dexmedotomidine is effective in the treatment of shivering associated with neuraxial anesthesia during cesarean delivery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
80
An intravenous bolus of dexmedetomidine 30 mcg (7,5 mL) administered at least five minutes after birth, in participants with shivering grade 3 or 4 on a scale described by Crossley and Mahajan.
An intravenous bolus of normal saline (7,5 mL) administered at least five minutes after birth, in participants with shivering grade 3 or 4 on a scale described by Crossley and Mahajan.
St-Justine's Hospital
Montreal, Quebec, Canada
Time for cessation of shivering after bolus (min)
Graded on a four point scale as per Crossley and Mahajan
Time frame: Within the first 15 minutes of administration of bolus
Incidence of bradycardia
Heart rate below 50 bpm
Time frame: From the administration of bolus to the end of surgery, an expected average of 1 hour
Incidence of hypotension
A decrease in mean arterial pressure by more than 20% of the baseline mean arterial pressure
Time frame: From the administration of bolus to the end of surgery, an expected average of 1 hour
Incidence of sedation
Graded on a four point scale as per Filos et al
Time frame: From the administration of bolus to the end of surgery, an expected average of 1 hour
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.